✦ LIBER ✦

Paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in advanced NSCLC. Final results of a randomized phase III study

✍ Scribed by P. Kosmidis; C. Bacoyiannis; N. Mylonakis; C. Nicolaides; C. Kalophonos; E. Samantas; J. Boukovinas; D. Skarlos; P. Papakostas; M.A. Dimoupoulos

Book ID: 117657956
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 345 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80586-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine Plus Paclitaxel Versus Carbo

Gemcitabine Plus Paclitaxel Versus Carboplatin Plus Either Gemcitabine or Paclitaxel in Advanced Non-small-cell Lung Cancer: A Literature-based Meta-analysis

✍ Chenguang Li; Yihua Sun; Yunjian Pan; Qifeng Wang; Shu Yang; Haiquan Chen 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 353 KB

O-92 Paclitaxel/carboplatin (PC) vs pacl

O-92 Paclitaxel/carboplatin (PC) vs paclitaxel/carboplatin/gemcitabine (PCG) in advanced NSCLC: Preliminary results of an ongoing phase II–III multicentric study

✍ Paccagnella, Adriano; Favaretto, Adolfo; Oniga, Francesco; Bearz, Alessandra; Cl 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 153 KB

O-217 A randomized phase III trial of ge

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Phase III trial of induction gemcitabine

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer

✍ Alan N. Gordon; Michael Teneriello; Mike F. Janicek; Jeffrey Hines; Peter C. Lim 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 367 KB

A multicenter randomized trial of paclit

A multicenter randomized trial of paclitaxel (175 mg/m2) plus carboplatin (6AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6AUC) in advanced non-small cell lung cancer (NSCLC)

✍ P.A. Kosmidis; N. Mylonakis; D. Skarlos; E. Samantas; M.A. Demopoulos; C. Papadi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Vinorelbine plus gemcitabine followed by

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

✍ Kaoru Kubota; Masaaki Kawahara; Mitsumasa Ogawara; Yutaka Nishiwaki; Kiyoshi Kom 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 173 KB